The PROMID study group now reports that octreotide LAR (long-acting release) has a substantial antitumor effect, with longer progression-free survival compared with placebo in patients with well ...

An intramuscular injection of 20 mg long-acting octreotide was administered every 4 weeks. After 2 months of treatment, a total-body CT scan was performed to assess the tumor response to this ...

Find all the commercial and brand names of generic drug called Octreotide. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...